Experimental protocol | The present study | Our previous report: Takeda et al. 2022 | ||||
---|---|---|---|---|---|---|
Exposure concentration (mg/m3) | 40 | 40 | 40 | 10 | 10 | 10 |
Recovery period (weeks) | 0 | 2 | 18 | 0 | 4 | 13 |
No. of animals examined | 6 | 6 | 10 | 8 | 8 | 8 |
Histopathological findings | Â | Â | Â | Â | Â | Â |
    Male lung |  |  |  |  |  |  |
       Granulomatous change, alveolar | 6 | 6 | 10 | 8 | 8 | 8 |
 |  < 2 >  |  < 2 >  |  < 1 >  |  < 1.9 >  |  < 1.9 >  |  < 1 >  |
        Multifocal lesion, alveolar |  |  |  |  |  |  |
            Hypertrophy/proliferation of alveolar epithelium | 6 | 6 | 10 | 8 | 8 | 8 |
 |  < 3 >  |  < 2 >  |  < 2 >  |  < 2 >  |  < 2 >  |  < 1.8 >  |
             Inflammation, air space | 6 | 6 | 10 | 8 | 8 | 8 |
 |  < 3 >  |  < 2 >  |  < 1 >  |  < 2 >  |  < 2 >  |  < 1 >  |
             Cholesterol cleft, air space | 0 | 0 | 10 | 0 | 8 | 8 |
 |  |  |  < 1 >  |  |  < 1 >  |  < 1 >  |
            Alveolitis | 0 | 0 | 10 | 0 | 3 | 8 |
 |  |  |  < 2 >  |  |  < 1 >  |  < 2 >  |
             Fibrous thickening, interstitial | 0 | 0 | 10 | 0 | 3 | 8 |
 |  |  |  < 1 >  |  |  < 1 >  |  < 1 >  |
        Accumulation of lipoproteinous material, air space | 6 | 6 | 0 | 8 | 6 | 8 |
 |  < 2.2 >  |  < 1.2 >  |  |  < 1.9 >  |  < 1 >  |  < 1 >  |